Correlation Between Merck and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Merck and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Qualigen Therapeutics, you can compare the effects of market volatilities on Merck and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Qualigen Therapeutics.
Diversification Opportunities for Merck and Qualigen Therapeutics
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Merck and Qualigen is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Merck i.e., Merck and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between Merck and Qualigen Therapeutics
Considering the 90-day investment horizon Merck Company is expected to generate 0.39 times more return on investment than Qualigen Therapeutics. However, Merck Company is 2.54 times less risky than Qualigen Therapeutics. It trades about -0.25 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 9,985 in Merck Company on November 9, 2024 and sell it today you would lose (1,180) from holding Merck Company or give up 11.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Qualigen Therapeutics
Performance |
| Timeline |
| Merck Company |
| Qualigen Therapeutics |
Merck and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Qualigen Therapeutics
The main advantage of trading using opposite Merck and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.The idea behind Merck Company and Qualigen Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |